LT - ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
EN - ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/675 |
|
|
|
A61K 45/06 |
|
|
|
A61K 31/196 |
|
|
|
A61K 31/415 |
|
|
|
A61K 31/425 |
|
|
|
A61K 31/4402 |
|
|
|
A61P 35/00 |
|
|
|
A61K 31/203 |
|
European patent
| (11) |
Number of the document |
2043659 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
07766866.3 |
|
Date of filing the European patent application |
2007-07-04 |
| (97) |
Date of publication of the European application |
2009-04-08 |
| (45) |
Date of publication and mention of the grant of the patent |
2013-04-03
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/IL2007/000836 |
|
Date |
2007-07-04 |
PCT application publication
| (87) |
Number |
WO 2008/004231 |
|
Date |
2008-01-10 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
819164 P |
2006-07-07
|
US |
|
880107 P |
2007-01-12
|
US |
Inventors
| (72) |
BEN-SASSON, Shmuel A., IL
|
Grantee
| (73) |
Tiltan Pharma Ltd,
1-1 Hi-Tech Village Edmond Safra Campus Givat Ram P.O.B. 39026, 91390 Jerusalem,
IL
|
Title
| (54) |
ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT |
| |
ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT |
